Skip to content
Riskpilot
← Back to search
Sign in
Get full access
MIP PHARMA DANMARK ApS
APS
Active
CVR 32886280
Store Kongensgade 40H, 1264
København K
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2010
— employees
Watchlist
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
MIP PHARMA DANMARK ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
-39
-48
-39
-92
-129
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-39
-48
-39
-92
-129
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-39
-48
-39
-92
-129
Net financials
-14
-31
-26
-17
-27
Profit before tax
-53
-79
-65
-109
-156
Tax
-0
-0
-0
-0
-0
Net profit
-53
-79
-65
-109
-156
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
22
25
22
38
31
Equity
-308
-387
-452
-561
-717
Long-term debt
307
336
447
561
681
Short-term debt
22
75
26
38
67
Total debt
330
411
474
599
748
Financial ratios
5-year trend
EBITDA margin
-12905200.0%
This company
15.8%
Market median
-81678581% vs market
2021
2025
Equity ratio
-2293.2%
This company
38.2%
Market median
-6103% vs market
2021
2025
Return on equity
-15564600.0%
This company
18.4%
Market median
-84590317% vs market
2021
2025
Net profit margin
-15564600.0%
This company
8.1%
Market median
-192155656% vs market
2021
2025
Asset turnover
-4.13×
This company
1.12×
Market median
-469% vs market
2021
2025
Debt / equity
1.04×
This company
0.62×
Market median
-68% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
View
PDF
More on MIP PHARMA DANMARK ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
